Use of recombinant factor IX (9) concentrates in Haemophilia B

Published: 10 December 2024

The purpose of this guideline is to provide clinical advice around the use of recombinant factor IX (9) in paediatric patients under the care of Queensland Children’s Hospital (QCH).

Files

Thumbnail of Use of recombinant factor IX (9) concentrates in Haemophilia B
  • Audience Health professionals; Staff
  • FormatDocument
  • Information typeStandards and guidelines
  • LanguageEnglish
  • Last updated10 December 2024

Topics